Nurse Practitioner, Family · Brick, NJ
NPI
1558713180
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1899 Route 88
Brick, NJ, 08724
Phone (732) 840-8177
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
957 services
Medicare patients, 2024
422
Average age 73
Drug cost, 2024
$184K
2,837 prescriptions
Company payments, 2025
$18.85
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle McNicholas was code 99213 (office e&m - established), 395 times for 299 patients. In total Michelle McNicholas billed 957 services in 45 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 395 | 299 | $44.22 | $17K |
| 81002 Clinical Chemistry | Office | 83 | 77 | $3.41 | $283 |
| 99214 Office E&M - Established | Office | 81 | 74 | $49.20 | $3,985 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 78 | 78 | $58.87 | $4,592 |
| G0008 Administration of influenza virus vaccine | Office | 47 | 47 | $29.40 | $1,382 |
| 90662 Vaccine Product | Office | 42 | 42 | $81.35 | $3,417 |
| 99215 Office E&M - Established | Office | 34 | 33 | $72.82 | $2,476 |
| 93000 Electrocardiogram | Office | 22 | 22 | $8.42 | $185 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 15 | 15 | $74.19 | $1,113 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 12 | 12 | $138.78 | $1,665 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 11 | 11 | $137.90 | $1,517 |
| 90480 Vaccine Administration | Office | 11 | 11 | $45.63 | $502 |
By year: 2022 $44K for 938 services; 2023 $41K for 897 services; 2024 $45K for 957 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 83 | 77 | $3.41 | $283 |
Medicare prescription drug claims, 2024
In 2024, the drug Michelle McNicholas prescribed most often to Medicare patients was Atorvastatin Calcium, with 215 prescriptions and refills. In total Michelle McNicholas wrote 2,837 Medicare prescriptions that cost $184K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 215 | 638 | 70 | $2,375 |
| Lisinopril Generic | 167 | 499 | 56 | $1,292 |
| Amlodipine Besylate Generic | 130 | 388 | 50 | $896 |
| Rosuvastatin Calcium Generic | 116 | 349 | 40 | $1,391 |
| Levothyroxine Sodium Generic | 105 | 301 | 32 | $1,236 |
| Losartan Potassium Generic | 88 | 263 | 25 | $599 |
| Omeprazole Generic | 79 | 241 | 27 | $1,438 |
| Ipratropium Bromide Generic | 73 | 76 | 67 | $1,332 |
| Escitalopram Oxalate Generic | 66 | 198 | 22 | $1,084 |
| Sertraline Hcl Generic | 66 | 196 | 19 | $483 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 57 | 67 | 21 | $1,508 |
| Metformin Hcl Generic | 55 | 163 | 23 | $291 |
| Montelukast Sodium Generic | 55 | 158 | 23 | $588 |
| Glipizide Er Glipizide | 44 | 132 | 16 | $727 |
| Alprazolam Generic | 43 | 45 | 19 | $370 |
Brand drugs: - claims; generic drugs: 2,579 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle McNicholas $18.85 ($18.85 in general payments such as food, travel and fees) from 1 company. The largest payer was Vertex Pharmaceuticals Incorporated with $18.85.
| Company | Payments | Amount |
|---|---|---|
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $18.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.